The FDA has even authorised a drug produced with cannabidiol for that intent (Epidiolex). Although the company only suggests it for two unusual sorts of childhood epilepsy called Lennox-Gastaut syndrome and Dravet syndrome. One particular concept is cannabis use could overactivate the cannabinoid